Sec Form 13D Filing - CARRONADE CAPITAL MANAGEMENT LP filing for - 2025-12-16

Item 3 is hereby amended and restated to read as follows: The Shares purchased by Carronade and held in the Managed Account were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). The aggregate purchase price of the 3,076,999 Shares beneficially owned by Carronade is approximately $59,215,306, excluding brokerage commissions. The aggregate purchase price of the 185,649 Shares held in the Managed Account is approximately $3,662,031, excluding brokerage commissions. The Shares purchased by each of Ms. Aboelnaga, Mr. Duster, Mr. Prieto and Ms. Schaible were purchased with personal funds. The aggregate purchase price of the 1,400 Shares beneficially owned by Ms. Aboelnaga is approximately $26,624.28, excluding brokerage commissions. The aggregate purchase price of the 8,900.329 Shares beneficially owned by Mr. Duster is approximately $157,619.87, excluding brokerage commissions. The aggregate purchase price of the 1,920 Shares beneficially owned by Mr. Prieto is approximately $35,050.07, excluding brokerage commissions. The aggregate purchase price of the 1,360 Shares beneficially owned by Ms. Schaible is approximately $25,586, excluding brokerage commissions.

Item 4 is hereby amended to add the following: According to the voting results from the Annual Meeting disclosed by the Issuer on Form 8-K filed with the Securities and Exchange Commission on December 16, 2025, Carronade's director nominees, Ms. Aboelnaga and Ms. Schaible, were elected to the Issuer's board of directors by shareholders. On December 12, 2025, Carronade issued a press release in connection with the Annual Meeting, a copy of which is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

Item 5(a) is hereby amended and restated to read as follows: The percentages used in this Schedule 13D are based upon 48,000,000 Shares outstanding, as of November 28, 2025, as reported by the Issuer in its Sum of the Parts report, dated November 28, 2025, which was posted on the Issuer's website. As of the date hereof, Carronade beneficially owns directly 3,076,999 Shares, representing approximately 6.4% of the outstanding Shares. Carronade Capital GP, as the general partner of Carronade, may be deemed the beneficial owner of the 3,076,999 shares of Common Stock owned directly by Carronade, representing approximately 6.4% of the outstanding Shares. As of the date hereof, 185,649 Shares were held in the Managed Account, representing approximately 0.4% of the outstanding Shares. Carronade Capital Management, as the investment manager of each of Carronade and the Managed Account, may be deemed the beneficial owner of the (i) 3,076,999 Shares beneficially owned directly by Carronade and (ii) 185,649 Shares held in the Managed Account, representing approximately 6.8% of the outstanding Shares. Carronade Capital Management GP, as the general partner of Carronade Capital Management, may be deemed the beneficial owner of the (i) 3,076,999 Shares beneficially owned directly by Carronade and (ii) 185,649 Shares held in the Managed Account, representing approximately 6.8% of the outstanding Shares. Mr. Gropper, as the Managing Member of Carronade Capital Management GP, may be deemed the beneficial owner of the (i) 3,076,999 Shares beneficially owned directly by Carronade and (ii) 185,649 Shares held in the Managed Account, representing approximately 6.8% of the outstanding Shares. As of the date hereof, Ms. Aboelnaga directly beneficially owns 1,400 shares of Common Stock, representing approximately 0.003% of the outstanding Shares. As of the date hereof, Mr. Duster directly beneficially owns 8,900.329 shares of Common Stock, representing approximately 0.019% of the outstanding Shares. As of the date hereof, Mr. Prieto directly beneficially owns 1,920 shares of Common Stock, representing approximately 0.004% of the outstanding Shares. As of the date hereof, Ms. Schaible directly beneficially owns 1,360 shares of Common Stock, representing approximately 0.003% of the outstanding Shares. The filing of this Amendment No. 2 shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer that he, she or it does not directly own. Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein that he, she or it does not directly own.

Item 5(c) is hereby amended to add the following: Information concerning transactions in the securities of the Issuer effected by the Reporting Persons during the past sixty days is set forth in Exhibit 1 attached hereto and is incorporated herein by reference. All of the transactions in the securities of the Issuer listed therein were effected in the open market through various brokerage entities.

Item 6 is hereby amended to add the following: On December 16, 2025, the Reporting Persons that will remain Reporting Persons after the filing of this Amendment No. 2 to the Schedule 13D entered into a Joint Filing Agreement in which the remaining Reporting Persons agreed to the joint filing on behalf of each of them of statements on Schedule 13D with respect to the securities of the Issuer to the extent required by applicable law. The Joint Filing Agreement is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

Item 7 is hereby amended to add the following exhibits: 1 - Transactions in Securities. 99.1 - Press Release, dated December 12, 2025. 99.2 - Joint Filing Agreement, dated December 16, 2025.